Current Medical Research and Opinion

Role of pharmacoepidemiology in evaluating prescription drug safety in pediatrics
pp. 2607-2615(9)
Authors: Luo, Xuemei; Doherty, Jim; Cappelleri, Joseph C.; Frush, Karen

Long dosing intervals in the treatment of postmenopausal osteoporosis
pp. 2617-2625(9)
Author: Lewiecki, E. Michael

Comment and Reply on: International Society for Medical Publication Professionals (ISMPP) position statement: the role of the professional medical writer
pp. 2627-2628(2)
Authors: Donovan, Daniel J.; Gegeny, Thomas; Norris, Robert; Fagan, Jean M.; Gallagher, Eileen R.; Geraci, Anna B.; Gertel, Art; Hirsch, Laurence; Ross, Philip D.; Stossel, Thomas P.; Veitch, Keith; Woods, David

Efficacy, tolerability and comfort of a 0.3% hypromellose gel ophthalmic lubricant in the treatment of patients with moderate to severe dry eye syndrome
pp. 2629-2636(8)
Author: Tauber, Joseph

A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis
pp. 2637-2645(9)
Authors: Klausner, Howard A.; Brown, Patricia; Peterson, Janet; Kaul, Simrati; Khashab, Mohammed; Fisher, Alan C.; Kahn, James B.

International comparison of generic medicine prices
pp. 2647-2654(8)
Author: Simoens, Steven

Measuring functional performance in patients with COPD: a discussion of patient-reported outcome measures
pp. 2655-2665(11)
Authors: Stull, Donald E.; Leidy, Nancy Kline; Jones, Paul W.; Ståhl, Elisabeth

The potential role for cladribine in the treatment of multiple sclerosis: clinical experience and development of an oral tablet formulation
pp. 2667-2676(10)
Authors: Leist, Thomas P.; Vermersch, Patrick

Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women
pp. 2677-2687(11)
Authors: Ringe, J.D.; Christodoulakos, G.E.; Mellström, D.; Petto, H.; Nickelsen, T.; Marín, F.; Pavo, I.

A comparison of lipid and lipoprotein measurements in the fasting and nonfasting states in patients with type 2 diabetes
pp. 2689-2695(7)
Authors: Dungan, Kathleen M.; Guster, Tia; DeWalt, Darren A.; Buse, John B.

Long-term darifenacin treatment for overactive bladder in patients aged 65 years and older: analysis of results from a 2-year, open-label extension study
pp. 2697-2704(8)
Authors: Hill, Simon; Elhilali, Mostafa; Millard, Richard J.; Dwyer, Peter L.; Lheritier, Karine; Kawakami, Fernando T.; Steel, Michael

A review of compliance to treatment in Alzheimer's disease: potential benefits of a transdermal patch
pp. 2705-2713(9)
Authors: Small, Gary; Dubois, Bruno

Current pharmacologic treatment paradigms for inflammatory bowel disease and the potential role of granulocyte/monocyte apheresis
pp. 2715-2728(14)
Authors: Schwartz, David; Ferguson, John R.

Primary vaccination of adults with reduced antigen-content diphtheria-tetanus-acellular pertussis or dTpa-inactivated poliovirus vaccines compared to diphtheria-tetanus-toxoid vaccines
pp. 2729-2739(11)
Authors: Theeten, Heidi; Rümke, Hans; Hoppener, Floris J.P.; Vilatimó, Ramón; Narejos, Silvia; Van Damme, Pierre; Hoet, Bernard

Psychometric validation of the Patient Symptom Assessment in Lung Cancer instrument for small cell lung cancer
pp. 2741-2752(12)
Authors: Chen, Lei; Antras, Lucia; Duh, Mei Sheng; Levy, Natalie; Neary, Maureen; O'Brien, Mary E.R.; von Pawel, Joachim

Patient baseline characteristics in an open-label multinational study of betahistine in recurrent peripheral vestibular vertigo: the OSVaLD study
pp. 2753-2761(9)
Authors: Pérez-Garrigues, H.; Kuessner, D.; Benecke, H.

Comments on: Effects of clarithromycin in patients with active rheumatoid arthritis
pp. 2763-2764(2)
Authors: Saviola, Gianantonio; Benucci, Maurizio; Cirino, Giuseppe

Drug treatment discontinuation and achievement of target blood pressure and cholesterol in United Kingdom primary care
pp. 2765-2774(10)
Authors: MacDonald, Thomas M.; Morant, Steve V.; Mozaffari, Essy

Economic evaluation comparing From Home To Operation same day admission and preoperative admission one day prior to the surgery process : a randomized, controlled trial of laparoscopic cholecystectomy
pp. 2775-2784(10)
Authors: Keränen, J.; Soini, E.J.O.; Ryynänen, O.P.; Hietaniemi, K.; Keränen, U.

An evaluation of the association between systemic inflammation - as measured by C-reactive protein - and hospital resource use
pp. 2785-2792(8)
Authors: Poole, Chris D.; Conway, Pete; Currie, Craig J.

Comparison between spinal surgery blood transfusion services costs and associated treatment practices in the United States and Belgium
pp. 2793-2804(12)
Authors: Blanchette, Christopher M.; Joshi, Ashish V.; Szpalski, Marek; Gunzburg, Robert; Du Bois, Marc; Donceel, Peter; Saunders, William B.

Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder
pp. 2805-2814(10)
Authors: Zhu, Baojin; Kulkarni, Pandurang M.; Stensland, Michael D.; Ascher-Svanum, Haya

Incidence and costs of polypharmacy: data from a randomized, double-blind, placebo-controlled study of risperidone and quetiapine in patients with schizophrenia or schizoaffective disorder
pp. 2815-2822(8)
Authors: Rupnow, Marcia F.T.; Greenspan, Andrew; Gharabawi, Georges M.; Kosik-Gonzalez, Colette; Zhu, Young; Stahl, Stephen M.

Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosis
pp. 2823-2832(10)
Authors: Goodin, Douglas S.; Biermann, Louis D.; Bohlega, Saeed; Boiko, Alexey; Chofflon, Michel; Gebeily, Souheil; Gouider, Riadh; Havrdova, Eva; Jakab, Gabor; Karabudak, Rana; Karussis, Dimitrios; Miller, Ariel; Pakdaman, Hossein; Selmaj, Krzysztof; Sharief, Mohammad; The International Working Group for Treatment Optimization in MS,

Organisational barriers to thrombolysis treatment of acute ischaemic stroke
pp. 2833-2839(7)
Authors: Ehlers, Lars; Jensen, Lotte Groth; Bech, Merete A.; Andersen, Grethe; Kjølby, Mette

Erythropoietic growth factors for children with cancer: a systematic review of the literature
pp. 2841-2847(7)
Authors: Mystakidou, Kyriaki; Potamianou, Anna; Tsilika, Eleni

Thiazolidinedione use and post-operative atrial fibrillation: a US nested case-control study
pp. 2849-2855(7)
Authors: Anglade, Moise W.; Kluger, Jeffrey; White, C. Michael; Aberle, Jeffrey; Coleman, Craig I.

How do people with gastro-oesophageal reflux disease perceive their disease? Results of a multinational survey
pp. 2857-2865(9)
Authors: Ducrotté, Philippe; Liker, Harley R.

Estimated first-year costs of prostaglandin analogs with/without adjunctive therapy for glaucoma management: a United States perspective
pp. 2867-2875(9)
Authors: Schmier, Jordana K.; Covert, David W.; Robin, Alan L.

Efficacy and safety of valsartan 160/HCTZ 25 mg in fixed combination in hypertensive patients not controlled by candesartan 32 mg plus HCTZ 25 mg in free combination
pp. 2877-2885(9)
Authors: Schweizer, J.; Hilsmann, U.; Neumann, G.; Handrock, R.; Klebs, S.

The effect of fixed combination of fluticasone and salmeterol on asthma drug utilization, asthma drug cost, and episodes of asthma exacerbations
pp. 2887-2895(9)
Authors: Brixner, D.I.; Lenhart, G.; Young, D.C.; Samuelson, W.M.

Mometasone furoate dry powder inhaler: a once-daily inhaled corticosteroid for the treatment of persistent asthma
pp. 2897-2911(15)
Authors: Karpel, Jill P.; Nelson, Harold